{"&cites=18293974578737482045&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers","url":"https://link.springer.com/article/10.1186/1472-6963-10-153","authors":["J Adamski","J Adamski B Godman","J Adamski B Godman G Ofierska"],"year":2010,"numCitations":249,"pdf":"https://link.springer.com/article/10.1186/1472-6963-10-153","citationUrl":"http://scholar.google.com/scholar?cites=5867411617187961800&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:yBt9acc7bVEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=5867411617187961800&hl=en&as_sdt=2005&sciodt=0,5","publication":"Springer","p":1,"exp":1596876810135},{"title":"Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications","url":"https://www.tandfonline.com/doi/abs/10.1586/erp.10.72","authors":["B Godman","B Godman W Shrank","B Godman W Shrank M Andersen","B Godman W Shrank M Andersen C Berg…"],"year":2010,"numCitations":166,"pdf":"http://www.academia.edu/download/51475950/Comparing_policies_to_enhance_prescribin20170123-25558-8t52q9.pdf","citationUrl":"http://scholar.google.com/scholar?cites=14266846914305676945&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:kVYR-K0F_sUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14266846914305676945&hl=en&as_sdt=2005&sciodt=0,5","publication":"Taylor & Francis"},{"title":"Impact of European pharmaceutical price regulation on generic price competition","url":"https://link.springer.com/article/10.2165/11535360-000000000-00000","authors":["J Puig"],"year":2010,"numCitations":126,"pdf":"https://jaumepuigjunoy.cat/wp-content/uploads/2017/07/pe_puig_junoy.pdf","citationUrl":"http://scholar.google.com/scholar?cites=8502518287677436262&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ZrFGmVUD_3UJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=8502518287677436262&hl=en&as_sdt=2005&sciodt=0,5","publication":"Springer"},{"title":"Policies to enhance prescribing efficiency in Europe: findings and future implications","url":"https://www.frontiersin.org/articles/10.3389/fphar.2010.00141","authors":["B Godman","B Godman W Shrank","B Godman W Shrank M Andersen","B Godman W Shrank M Andersen C Berg…"],"year":2011,"numCitations":125,"pdf":"https://www.frontiersin.org/articles/10.3389/fphar.2010.00141","citationUrl":"http://scholar.google.com/scholar?cites=9011910708921240118&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:NgrK6Aq9EH0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9011910708921240118&hl=en&as_sdt=2005&sciodt=0,5","publication":"frontiersin.org"},{"title":"Use of generics—a critical cost containment measure for all healthcare professionals in Europe?","url":"https://www.mdpi.com/1424-8247/3/8/2470","authors":["B Godman","B Godman W Shrank","B Godman W Shrank B Wettermark","B Godman W Shrank B Wettermark M Andersen…"],"year":2010,"numCitations":104,"pdf":"https://www.mdpi.com/1424-8247/3/8/2470/pdf","citationUrl":"http://scholar.google.com/scholar?cites=15396177834864189607&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:p6DSGSs2qtUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15396177834864189607&hl=en&as_sdt=2005&sciodt=0,5","publication":"mdpi.com"},{"title":"Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future …","url":"https://www.frontiersin.org/articles/10.3389/fphar.2014.00106/full","authors":["B Godman","B Godman B Wettermark","B Godman B Wettermark M Van Woerkom…"],"year":2014,"numCitations":101,"pdf":"https://www.frontiersin.org/articles/10.3389/fphar.2014.00106/full","citationUrl":"http://scholar.google.com/scholar?cites=1944564551247697025&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:gZTvFyh7_BoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1944564551247697025&hl=en&as_sdt=2005&sciodt=0,5","publication":"frontiersin.org"},{"title":"Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland","url":"https://www.tandfonline.com/doi/abs/10.1586/erp.11.98","authors":["M Bennie","M Bennie B Godman","M Bennie B Godman I Bishop…"],"year":2012,"numCitations":96,"pdf":"https://www.researchgate.net/profile/Iain_Bishop/publication/221780151_Multiple_initiatives_continue_to_enhance_the_prescribing_efficiency_for_the_proton_pump_inhibitors_and_statins_in_Scotland/links/54dc788f0cf28d3de65fe80f.pdf","citationUrl":"http://scholar.google.com/scholar?cites=16775566803553640147&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:016mhyDJzugJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16775566803553640147&hl=en&as_sdt=2005&sciodt=0,5","publication":"Taylor & Francis"},{"title":"Policies for biosimilar uptake in Europe: an overview","url":"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0190147","authors":["E Moorkens","E Moorkens AG Vulto","E Moorkens AG Vulto I Huys","E Moorkens AG Vulto I Huys P Dylst","E Moorkens AG Vulto I Huys P Dylst B Godman…"],"year":2017,"numCitations":92,"pdf":"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0190147","citationUrl":"http://scholar.google.com/scholar?cites=11736999427751836745&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:SXwcVMsy4qIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11736999427751836745&hl=en&as_sdt=2005&sciodt=0,5","publication":"journals.plos.org"},{"title":"Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs","url":"https://www.frontiersin.org/articles/10.3389/fphar.2013.00039/full","authors":["R Malmstrom","R Malmstrom B Godman","R Malmstrom B Godman E Diogene…"],"year":2013,"numCitations":88,"pdf":"https://www.frontiersin.org/articles/10.3389/fphar.2013.00039/full","citationUrl":"http://scholar.google.com/scholar?cites=4795503353889609289&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:SdbIh-QMjUIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=4795503353889609289&hl=en&as_sdt=2005&sciodt=0,5","publication":"frontiersin.org"},{"title":"Influence of demand-side measures to enhance renin–angiotensin prescribing efficiency in Europe: implications for the future","url":"https://www.tandfonline.com/doi/abs/10.1586/erp.11.42","authors":["L Vončina","L Vončina T Strizrep","L Vončina T Strizrep B Godman…"],"year":2011,"numCitations":81,"pdf":"https://www.researchgate.net/profile/Iain_Bishop/publication/51561264_Influence_of_demand-side_measures_to_enhance_renin-angiotensin_prescribing_efficiency_in_Europe_Implications_for_the_future/links/54ddde050cf2814662eb9cb8.pdf","citationUrl":"http://scholar.google.com/scholar?cites=3093947839925153392&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:cG5TACvp7yoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3093947839925153392&hl=en&as_sdt=2005&sciodt=0,5","publication":"Taylor & Francis"}]}